ADVFN Logo ADVFN
Donnée du Marché
Actualité
Outils
Donnée du Marché
Discover

Hot Features

Follow Feed

Rester connecter avec les traders et investisseurs dans notre communauté Follow Feed.

Flux des Options

Explorez des données complètes sur les options et utilisez les filtres avancés avec Options Flow.

Moniteur

Organisez et surveillez vos d'actions et actifs avec le Moniteur.
Se connecter Premium IconPremium Help Menu
CAC 40
0,00
0,00%
Dow Jones
39 512,84
0,32%
DAX
18 772,85
0,50%
Brent Oil
82,355
-0,04%
Bitcoin
60 919,72
-0,86%
Registration Strip Icon for alerts Inscrivez-vous pour des alertes en temps réel, un portefeuille personnalisé et des mouvements de marché.
S'inscrire
  1. Accueil
  2. Investir
  3. Actions
  4. Etats-Unis
  5. NYSE
  6. Edwards Lifesciences Corp (EW)

  7. Edwards Lifesciences Corp (EW) Actualités

EW

Edwards Lifesciences (EW)

Edwards Lifesciences Corp
De:
Trier par:
 Showing the most relevant articles for your search:NYSE:EW
DateHeureSourceTitreSymboleSociété
10/05/202422h07Edgar (US Regulatory)Form 144 - Report of proposed sale of securitiesNYSE:EWEdwards Lifesciences Corp
10/05/202401h43Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNYSE:EWEdwards Lifesciences Corp
09/05/202411h13Business WireEdwards stellt Herzklappenmodell SAPIEN 3 Ultra RESILIA mit Technologie für verbesserte Haltbarkeit in Europa vorNYSE:EWEdwards Lifesciences Corp
09/05/202411h13Business WireEdwards lance la valve SAPIEN 3 Ultra RESILIA en Europe avec une technologie pour améliorer la durabilitéNYSE:EWEdwards Lifesciences Corp
09/05/202401h21Business WireEdwards Launches the SAPIEN 3 Ultra RESILIA Valve in Europe With Technology to Enhance DurabilityNYSE:EWEdwards Lifesciences Corp
08/05/202422h52Edgar (US Regulatory)Form 8-K - Current reportNYSE:EWEdwards Lifesciences Corp
07/05/202423h47Edgar (US Regulatory)Form 3 - Initial statement of beneficial ownership of securitiesNYSE:EWEdwards Lifesciences Corp
25/04/202422h15Business WireEdwards Lifesciences Reports First Quarter ResultsNYSE:EWEdwards Lifesciences Corp
18/04/202413h10Business WireEdwards Lifesciences to Host Earnings Conference Call on April 25, 2024NYSE:EWEdwards Lifesciences Corp
07/04/202422h30Business WireStudy of NFL Alumni Cohort Finds Majority Suffer From Heart Disease Without Knowing ItNYSE:EWEdwards Lifesciences Corp
11/03/202419h00Business WireLarge, Real-world Studies Demonstrate Continued Excellent Outcomes for Patients Receiving Edwards SAPIEN TAVRNYSE:EWEdwards Lifesciences Corp
23/02/202413h05Business WireEdwards Lifesciences to Present at the 44th Annual TD Cowen Healthcare ConferenceNYSE:EWEdwards Lifesciences Corp
12/02/202422h47Edgar (US Regulatory)Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]NYSE:EWEdwards Lifesciences Corp
06/02/202422h15Business WireEdwards Lifesciences Reports Fourth Quarter ResultsNYSE:EWEdwards Lifesciences Corp
02/02/202413h00Business WireEdwards’ EVOQUE Valve Replacement System First Transcatheter Therapy to Earn FDA Approval for Tricuspid ValveNYSE:EWEdwards Lifesciences Corp
30/01/202413h05Business WireEdwards Lifesciences to Host Earnings Conference Call on February 6, 2024NYSE:EWEdwards Lifesciences Corp
25/01/202419h48Edgar (US Regulatory)Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]NYSE:EWEdwards Lifesciences Corp
02/01/202415h00Business WireEdwards Lifesciences to Present at the 42nd Annual J.P. Morgan Healthcare ConferenceNYSE:EWEdwards Lifesciences Corp
07/12/202314h30Business WireEdwards Lifesciences Outlines Growth Strategy at Annual Investor ConferenceNYSE:EWEdwards Lifesciences Corp
28/11/202313h06IH Market NewsKeep An Eye Out: Pre-Market Movers And Analyst RecommendationsNYSE:EWEdwards Lifesciences Corp
27/10/202322h49Edgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]NYSE:EWEdwards Lifesciences Corp
26/10/202321h06PR Newswire (US)CLASP IID ONE-YEAR DATA CONFIRM SAFETY AND EFFICACY OF EDWARDS PASCAL SYSTEM FOR DEGENERATIVE MITRAL REGURGITATIONNYSE:EWEdwards Lifesciences Corp
26/10/202320h00PR Newswire (US)TRISCEND II SIX-MONTH DATA FOR FIRST 150 PATIENTS SUCCESSFULLY DEMONSTRATE SAFETY AND EFFICACY OF EDWARDS EVOQUE SYSTEM FOR SEVERE TRICUSPID REGURGITATIONNYSE:EWEdwards Lifesciences Corp
25/10/202322h15PR Newswire (US)EDWARDS LIFESCIENCES REPORTS THIRD QUARTER RESULTSNYSE:EWEdwards Lifesciences Corp
24/10/202320h00PR Newswire (US)FIVE-YEAR DATA FROM PARTNER 3 TRIAL DEMONSTRATE EXCELLENT SURVIVAL FOR PATIENTS RECEIVING EDWARDS SAPIEN 3 VALVENYSE:EWEdwards Lifesciences Corp
19/10/202314h30PR Newswire (US)EDWARDS EVOQUE TRANSCATHETER TRICUSPID VALVE REPLACEMENT SYSTEM RECEIVES CE MARKNYSE:EWEdwards Lifesciences Corp
18/10/202313h05PR Newswire (US)EDWARDS LIFESCIENCES TO HOST EARNINGS CONFERENCE CALL ON OCTOBER 25, 2023NYSE:EWEdwards Lifesciences Corp
08/09/202316h08IH Market NewsKeep An Eye Out: Pre-Market Movers And RecommendationsNYSE:EWEdwards Lifesciences Corp
28/08/202314h10PR Newswire (US)EDWARDS LIFESCIENCES TO PRESENT AT THE 2023 WELLS FARGO HEALTHCARE CONFERENCENYSE:EWEdwards Lifesciences Corp
02/08/202317h58Dow Jones NewsCorrection to Edwards Lifesciences 2Q Net Headline on July 26NYSE:EWEdwards Lifesciences Corp
 Showing the most relevant articles for your search:NYSE:EW

Dernières Valeurs Consultées

SUSHI
KONOETH
Konomi
COIN
TNBEUR
Time New Bank
Delayed Upgrade Clock
ADVFN Logo

France
Société
Entreprise
Popular
Obtenir l'application

Assistance: support@advfn.fr

En accédant aux services disponibles de ADVFN, vous acceptez les Conditions Générales de ADVFN Conditions Générales

© 2024 ADVFN PLC - Tous droits réservés